Join

Compare · QDEL vs TKNO

QDEL vs TKNO

Side-by-side comparison of QuidelOrtho Corporation (QDEL) and Alpha Teknova Inc. (TKNO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both QDEL and TKNO operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
  • QDEL is the larger of the two at $789.1M, about 4.6x TKNO ($170.5M).
  • Over the past year, QDEL is down 60.0% and TKNO is down 52.5% - TKNO leads by 7.6 points.
  • QDEL has been more active in the news (9 items in the past 4 weeks vs 3 for TKNO).
  • QDEL has more recent analyst coverage (18 ratings vs 7 for TKNO).
PerformanceQDEL-60.03%TKNO-52.46%
2025-04-28+0.00%2026-04-24
MetricQDELTKNO
Company
QuidelOrtho Corporation
Alpha Teknova Inc.
Price
-
-
Market cap
$789.1M
$170.5M
1M return
-27.67%
+4.59%
1Y return
-60.03%
-52.46%
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
9
3
Recent ratings
18
7
QDEL

QuidelOrtho Corporation

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.

Latest QDEL

Latest TKNO